Gilead Sciences to acquire Calistoga Pharmaceuticals for $375 million
22 February 2011 | By Gilead Sciences
Gilead Sciences, Inc. & Calistoga Pharmaceuticals, Inc., announced the signing of a definitive agreement pursuant to which Gilead will acquire Calistoga for $375 million...